CORTICAL STEROIDS IN TREATMENT OF CANCER

Samuel G. Taylor

Journal of the American Medical Association · 1950 · 67 citations · 8 references

Concepts

Abstract

It is now well established that androgenic and estrogenic steroids produce temporary regression of malignant tissue of the breast<sup>1</sup>in certain cases and that estrogenic steroids also have an anticarcinogenic effect on prostatic cancer.<sup>2</sup>There is also some evidence that progesterone may have a similar effect on carcinoma of the cervix,<sup>3</sup>breast<sup>4</sup>and prostate.<sup>5</sup>When pituitary adrenocorticotropic hormone (ACTH) and cortisone became available for clinical trial, it seemed logical to attempt to evaluate their effect on various types of malignant lesions. Murphy and Sturm<sup>6</sup>reported favorable results on transplanted leukemia in rats with pituitary adrenocorticotropic hormone or adrenal cortical extract. Heilman and Kendall<sup>7</sup>produced an arrest of the growth of malignant lymphoid tumor in the mouse with the administration of cortisone. Pearson and others<sup>8</sup>have reported temporary remission in Hodgkin's disease, acute leukemia and chronic lymphatic leukemia in man after use of

References

8